Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

NEOG vs QDEL: stock comparison and AI forecast

Neogen Corp (NEOG) and Quidelortho Corp (QDEL) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · In Vitro & In Vivo Diagnostic Substances

NEOG Neogen Corp

Price
$11.76 +27.1% · 6M
Market Cap
$2.57B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
Nasdaq · In Vitro & In Vivo Diagnostic Substances

QDEL Quidelortho Corp

Price
$10.70 -0.6% · 6M
Market Cap
$734M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-07 → 2026-11-06

Six-month price performance

Closing prices rebased to 100 at the start of the window.

100120140160
NEOG +27.1% QDEL -0.6%
NEOG · QDEL

Key facts

  • NEOG is 3.5 times larger than QDEL by market capitalization ($2.57B against $734M).
  • Over the last six months NEOG returned +27.1% and QDEL -0.6%.
  • NEOG turns -5.8% of its revenue into net income, against -11.5% for QDEL.
  • QDEL carries 2.23 times debt per unit of equity, against 0.58 times for NEOG.
  • Both companies share the SEC industry classification In Vitro & In Vivo Diagnostic Substances.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricNEOGQDEL
Market Cap$2.57B$734M
P/B Ratio1.23x0.41x
EPS$-0.26$-6.79
Book Value/Share$9.56$26.12
Revenue/Share$4.05$46.85
FCF/Share$0.23$-4.70

Profitability & Margins

MetricNEOGQDEL
ROE-2.5%-20.6%
ROA-1.6%-6.4%
ROIC-0.2%-3.4%
Gross Margin47.4%55.0%
Operating Margin-0.8%-5.0%
Net Margin-5.8%-11.5%
EBT Margin-7.7%-12.9%
Tax Rate17.1%-10.9%

Financial Health

MetricNEOGQDEL
Current Ratio3.90x1.36x
Quick Ratio2.92x0.75x
D/E Ratio0.58x2.23x
Financial Leverage1.58x3.23x
Interest Coverage-0.1x-0.4x
Working Capital$433M$379M

Cash Flow

MetricNEOGQDEL
Operating Cash Flow$85M-$253M
Free Cash Flow$50M-$322M
Capital Spending-$36M-$69M
OCF Growth YoY-2.0%-214.7%
FCF Growth YoY–-769.1%
FCF/Sales5.6%-10.0%
CapEx/Sales4.0%2.2%

Operational Efficiency

MetricNEOGQDEL
Asset Turnover0.27x0.56x
Receivables Turnover6.5x8.6x
Inventory Turnover3.2x2.2x
Fixed Assets Turnover2.7x2.4x
Days Sales Outstanding56 days43 days
Days Inventory115 days162 days
Payables Period61 days64 days
Cash Conversion Cycle110 days141 days

Income Statement

MetricNEOGQDEL
Total Revenue$884M$3.21B
Operating Income-$7M-$159M
Net Income-$52M-$369M
R&D Expense$20M$227M
SG&A Expense$430M$965M
Cost of Goods Sold$465M$1.45B

Dividend & Shareholder Information

MetricNEOGQDEL
Shares Outstanding218M69M
FAQ

NEOG vs QDEL: stock comparison and AI forecast

Which is bigger, NEOG or QDEL?

NEOG is 3.5 times larger than QDEL by market capitalization ($2.57B against $734M).

Which stock performed better over the last six months, NEOG or QDEL?

Over the last six months NEOG returned +27.1% and QDEL -0.6%.

Which one does Intratio's AI model rank higher, NEOG or QDEL?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.